Showing 5,806 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Starting treatment

Starting treatment on the day of HIV diagnosis is acceptable and feasible for Thai patients

News
17 August 2018
New & experimental HIV treatments

New HIV therapy reduces virus, boosts immunity in drug-resistant patients

Editor's pick
Science Daily
16 August 2018
New & experimental HIV treatments

Should Gilead Be Worried About This New Monthly HIV Medication?

Editor's pick
Motley Fool
16 August 2018
PrEP

HIV drug research in Wales to cut infection risk

Editor's pick
BBC
16 August 2018
Treatment interruptions

One in nine people may be able to control their viral load after stopping treatment, US study finds

News
16 August 2018
New & experimental HIV treatments

ViiV, Janssen’s two-drug HIV regimen hits PhIII targets

Editor's pick
Pharma Times
15 August 2018
Treatment for women

Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

Editor's pick
The Body PRO
15 August 2018
Cardiovascular disease

Treatment with modern antiretrovirals doesn't increase the risk of hypertension

News
14 August 2018
Changing treatment

Studies show dolutegravir monotherapy is an unsafe switch option

News
9 August 2018
Health problems & ageing

Diarrhoea continues to affect the quality of life of people with HIV in the modern treatment era

News
7 August 2018
New & experimental HIV treatments

How Will Long-Acting HIV Antiretrovirals Work in the Real World?

Editor's pick
The Body Pro
1 August 2018
New & experimental HIV treatments

Doravirine maintains higher rate of virological suppression over darunavir/ritonavir though 96 weeks of follow-up

News
30 July 2018
Changing treatment

Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed

News
30 July 2018
Treatment outcomes & life expectancy

Three-quarters of deaths of people with HIV in London are due to non-AIDS conditions

News
28 July 2018
The search for a cure

The kick that didn’t kill: first-ever randomised HIV cure study fails to eliminate infected cells

News
26 July 2018
Government, leadership & policy

Why are some countries slow to implement HIV treatment guidelines?

News
25 July 2018
Treatment simplification strategies

Dolutegravir dual therapy works well for first-time HIV treatment

News
25 July 2018
PrEP science

PrEP does not lower feminising hormone level in transgender women

News
25 July 2018
Treatment for women

Dolutegravir: update on infant neural tube defects from Botswana

News
24 July 2018
Treatment guidelines

Dolutegravir-based ART recommended for all – if reliable contraception is available

News
24 July 2018
Starting treatment

Brazil confirms dolutegravir is the most effective drug for first-line HIV treatment

News
24 July 2018
Undetectable viral load & treatment as prevention

Australian doctors to tell HIV patients that 'undetectable=untransmissible'

Editor's pick
Gay Star News
24 July 2018
New & experimental HIV treatments

The 2018 Pipeline Report

Editor's pick
TAG
24 July 2018
HIV treatment

Benefits, Risks of Dolutegravir Center Stage at AIDS 2018

Editor's pick
Medscape (requires free registration)
18 July 2018